Document Detail


Anti-atherosclerotic activity of triacsin C, an acyl-CoA synthetase inhibitor.
MedLine Citation:
PMID:  18653998     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
As previously reported, triacsin C, a selective inhibitor of acyl-CoA synthetase, inhibited the synthesis of cholesteryl ester and triacylglycerol in mouse peritoneal macrophages, leading to a reduction of lipid droplets. Therefore, the in vivo efficacy was studied. Low-density lipoprotein receptor-knockout (LDLR-/-) mice were fed a high cholesterol diet (0.15%) for two months to measure the atherogenic areas of the hearts and aortas. When triacsin C was orally administered (10 mg/kg/day), the atherosclerotic areas were significantly reduced by 86% in aorta and 36% in hearts. The results strongly suggested that triacsin C shows anti-atherogenic activity by inhibiting acyl-CoA synthetase activity.
Authors:
Daisuke Matsuda; Ichiji Namatame; Taichi Ohshiro; Shun Ishibashi; Satoshi Omura; Hiroshi Tomoda
Related Documents :
2761358 - Effect of dietary fat on individual long-chain fatty acyl-coa esters in rat liver and s...
7972268 - Comparison of the effectiveness of eicosapentaenoic acid administered as either the fre...
6743678 - Demonstration of intact intracellular cholesterol esterification and normal low-density...
10498408 - Microsomal long chain fatty acyl-coa transacylation: differential effect of sterol carr...
21319208 - Effects of diet on the chemical composition of migratory locusts (locusta migratoria).
22142278 - Moderators of the mediated effect of intentions, planning, and saturated-fat intake in ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Journal of antibiotics     Volume:  61     ISSN:  0021-8820     ISO Abbreviation:  J. Antibiot.     Publication Date:  2008 May 
Date Detail:
Created Date:  2008-07-25     Completed Date:  2008-10-17     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0151115     Medline TA:  J Antibiot (Tokyo)     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  318-21     Citation Subset:  IM    
Affiliation:
School of Pharmacy, Kitasato University, Shirokane, Tokyo, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Aorta, Thoracic / pathology
Atherosclerosis / pathology,  prevention & control*
Blood Glucose / metabolism
Body Weight / drug effects
Cholesterol / blood
Cholesterol, Dietary / toxicity
Coenzyme A Ligases / antagonists & inhibitors*
Enzyme Inhibitors / pharmacology*
Fatty Acids, Nonesterified / blood
Mice
Mice, Knockout
Myocardium / pathology
Receptors, LDL / genetics
Streptomyces / chemistry,  metabolism
Triazenes / isolation & purification,  pharmacology*
Triglycerides / blood
Chemical
Reg. No./Substance:
0/Blood Glucose; 0/Cholesterol, Dietary; 0/Enzyme Inhibitors; 0/Fatty Acids, Nonesterified; 0/Receptors, LDL; 0/Triazenes; 0/Triglycerides; 57-88-5/Cholesterol; 76896-80-5/triacsin C; EC 6.2.1.-/Coenzyme A Ligases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  SAR study of a novel triene-ansamycin group compound, quinotrierixin, and related compounds, as inhi...
Next Document:  Structural investigations of mode of action of drugs: structure and conformation of a novel peptidyl...